Rooney CM - Search Results

1

CD70-specific CAR T cells have potent activity against acute myeloid leukemia without HSC toxicity.

Sauer T, Parikh K, Sharma S, Omer B, Sedloev D, Chen Q, Angenendt L, Schliemann C, Schmitt M, Müller-Tidow C, Gottschalk S, Rooney CM. Sauer T, et al. Among authors: rooney cm. Blood. 2021 Jul 29;138(4):318-330. doi: 10.1182/blood.2020008221. Blood. 2021. PMID: 34323938 Free PMC article.

2

Gene-marking and haemopoietic stem-cell transplantation.

Heslop HE, Rooney CM, Brenner MK. Heslop HE, et al. Among authors: rooney cm. Blood Rev. 1995 Dec;9(4):220-5. doi: 10.1016/s0268-960x(95)90013-6. Blood Rev. 1995. PMID: 8839397 Review.

3

Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes for the treatment of patients with EBV-positive relapsed Hodgkin's disease.

Roskrow MA, Suzuki N, Gan Yj, Sixbey JW, Ng CY, Kimbrough S, Hudson M, Brenner MK, Heslop HE, Rooney CM. Roskrow MA, et al. Among authors: rooney cm. Blood. 1998 Apr 15;91(8):2925-34. Blood. 1998. PMID: 9531603 Free article. Clinical Trial.

4

Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients.

Rooney CM, Smith CA, Ng CY, Loftin SK, Sixbey JW, Gan Y, Srivastava DK, Bowman LC, Krance RA, Brenner MK, Heslop HE. Rooney CM, et al. Blood. 1998 Sep 1;92(5):1549-55. Blood. 1998. PMID: 9716582 Free article.

5

CD20 monoclonal antibody (rituximab) for therapy of Epstein-Barr virus lymphoma after hemopoietic stem-cell transplantation.

Kuehnle I, Huls MH, Liu Z, Semmelmann M, Krance RA, Brenner MK, Rooney CM, Heslop HE. Kuehnle I, et al. Among authors: rooney cm. Blood. 2000 Feb 15;95(4):1502-5. Blood. 2000. PMID: 10666232 Free article.

6

An Epstein-Barr virus deletion mutant associated with fatal lymphoproliferative disease unresponsive to therapy with virus-specific CTLs.

Gottschalk S, Ng CY, Perez M, Smith CA, Sample C, Brenner MK, Heslop HE, Rooney CM. Gottschalk S, et al. Among authors: rooney cm. Blood. 2001 Feb 15;97(4):835-43. doi: 10.1182/blood.v97.4.835. Blood. 2001. PMID: 11159505 Free article.

7

Adenoviral gene transfer into dendritic cells efficiently amplifies the immune response to LMP2A antigen: a potential treatment strategy for Epstein-Barr virus--positive Hodgkin's lymphoma.

Gahn B, Siller-Lopez F, Pirooz AD, Yvon E, Gottschalk S, Longnecker R, Brenner MK, Heslop HE, Aguilar-Cordova E, Rooney CM. Gahn B, et al. Among authors: rooney cm. Int J Cancer. 2001 Sep 1;93(5):706-13. doi: 10.1002/ijc.1396. Int J Cancer. 2001. PMID: 11477583

8

Diagnosis and treatment of posttransplantation lymphoproliferative disease after hematopoietic stem cell transplantation.

Wagner HJ, Rooney CM, Heslop HE. Wagner HJ, et al. Among authors: rooney cm. Biol Blood Marrow Transplant. 2002;8(1):1-8. doi: 10.1053/bbmt.2002.v8.pm11846351. Biol Blood Marrow Transplant. 2002. PMID: 11846351 Free article. Review.

9

Epstein-Barr virus-specific human T lymphocytes expressing antitumor chimeric T-cell receptors: potential for improved immunotherapy.

Rossig C, Bollard CM, Nuchtern JG, Rooney CM, Brenner MK. Rossig C, et al. Among authors: rooney cm. Blood. 2002 Mar 15;99(6):2009-16. doi: 10.1182/blood.v99.6.2009. Blood. 2002. PMID: 11877273 Free article.

10

Adapting a transforming growth factor beta-related tumor protection strategy to enhance antitumor immunity.

Bollard CM, Rössig C, Calonge MJ, Huls MH, Wagner HJ, Massague J, Brenner MK, Heslop HE, Rooney CM. Bollard CM, et al. Among authors: rooney cm. Blood. 2002 May 1;99(9):3179-87. doi: 10.1182/blood.v99.9.3179. Blood. 2002. PMID: 11964281 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

343 results

Search Page

Filters